SANA / Sana Biotechnology, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Sana Biotechnology, Inc.
US ˙ NasdaqGS ˙ US7995661045

Deler fremragende 277,499,260 shares
Insideraktier93.665.391 shares
Insider ejerskab34,14 %
Total Insiders23
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
5696 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
6488 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Sana Biotechnology, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Noubar Afeyan 10% Owner - [10%] 11.585.199 0
Sunil Agarwal EVP, Head of Development & CMO - [O] 1.550.000 1.550.000
ARCH Venture Fund X, L.P. 10% Owner - [10%] 22.747.272 22.747.272
ARCH Venture Partners X, LLC 10% Owner - [10%] 11.718.750 22.747.272
Bilenker Joshua H. Director - [D] 20.000 20.000
Hans Edgar Bishop Director - [D] 5.848.503 5.848.503
Keith Crandell 10% Owner - [10%] 22.747.272 22.747.272
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Bernard J Cassidy EVP & General Counsel - [O] 112.990 112.990
FMR LLC / Fidelity Management & Research 10% Owner - [10%] 4.541.572 4.541.572
Flagship Ventures Fund V General Partner LLC 10% Owner - [10%] 22.546.725 0
Flagship Ventures Management, Inc. 10% Owner - [10%] 0 0
Steven Gillis 10% Owner - [10%] 11.718.750 22.747.272
Nathan Hardy SVP, Chief Financial Officer - [O] 511.250 511.250
Steve Harr President & CEO, Director - [D] [O] 7.944.251 7.944.251
Christian Hordo EVP, Chief Business Officer - [O] 867.455 867.455
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
MacDonald James J. EVP & General Counsel - [O] 497.396 497.396
Richard Mulligan Director - [D] 2.698.121 2.698.121
Robert Nelsen Director, 10% Owner - [D] [10%] 22.761.125 22.761.125
Dhavalkumar Dhirajlal Patel EVP, Chief Scientific Officer - [O] 99.510 99.510
Mary Agnes Wilderotter Director - [D] 7.106 7.106
Wyrick Susan D. See Remarks - [O] 196.196 196.196
Patrick Y Yang Director - [D] 149.250 149.250
Maltzahn Geoffrey von Director - [D] 366.122 366.122

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i SANA / Sana Biotechnology, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-02-08 ARCH Venture Fund X, L.P. 727.272 5,5000 727.272 5,5000 3.999.996 22 11.2700 4.196.359 104,91
2024-02-08 ARCH Venture Fund X, L.P. 363.637 5,5000 363.637 5,5000 2.000.004
2024-02-08 ARCH Venture Fund X, L.P. 727.272 5,5000 727.272 5,5000 3.999.996
2022-03-21 Yang Patrick Y 28.000 7,3000 28.000 7,3000 204.400
2021-02-03 Bilenker Joshua H. 20.000 25,0000 20.000 25,0000 500.000

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SANA / Sana Biotechnology, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i SANA / Sana Biotechnology, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-01-08 FMR LLC / Fidelity Management & Research 100.000 6,1100 100.000 6,1100 611.000 90 1.3400 -477.000 -78,07
2025-01-08 FMR LLC / Fidelity Management & Research 25.000 6,5000 25.000 6,5000 162.500
2025-01-08 FMR LLC / Fidelity Management & Research 164.912 6,7100 164.912 6,7100 1.106.560
2025-01-08 FMR LLC / Fidelity Management & Research 1.000 7,2600 1.000 7,2600 7.260
2024-03-08 Yang Patrick Y 25.000 9,4520 25.000 9,4520 236.300
2023-06-07 Flagship Ventures Fund V General Partner LLC 177.240 6,2397 177.240 6,2397 1.105.924
2023-06-07 Flagship Ventures Fund V General Partner LLC 22.760 6,2397 22.760 6,2397 142.016
2023-06-06 Flagship Ventures Fund V General Partner LLC 181.461 6,3061 181.461 6,3061 1.144.311
2023-06-06 Flagship Ventures Fund V General Partner LLC 22.297 6,3061 22.297 6,3061 140.607

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

SANA / Sana Biotechnology, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-04-08 2026-04-06 4 Bishop Hans Edgar SANA Common Stock A - Award D 7.763 5.848.503
2026-03-27 3 PATEL DHAVALKUMAR DHIRAJLAL SANA Common Stock D 99.510
2026-03-10 2026-03-09 4 Harr Steve SANA Common Stock F - Taxes D 3,1000 -12.819 -40 7.944.251
2026-03-10 2026-03-09 4 Harr Steve SANA Common Stock F - Taxes D 3,1300 -11.526 -36 7.957.070
2026-03-10 2026-03-07 4 Harr Steve SANA Common Stock M - Exercise D 50.000 7.968.596
2026-03-10 2026-03-06 4 Harr Steve SANA Common Stock M - Exercise D 41.666 7.918.596
2026-03-10 2026-03-09 4 Wyrick Susan D. SANA Common Stock F - Taxes D 3,1000 -1.045 -3 196.196
2026-03-10 2026-03-09 4 Wyrick Susan D. SANA Common Stock F - Taxes D 3,1300 -3.342 -10 197.241
2026-03-10 2026-03-07 4 Wyrick Susan D. SANA Common Stock M - Exercise D 3.250 200.583
2026-03-10 2026-03-06 4 Wyrick Susan D. SANA Common Stock M - Exercise D 10.416 197.333
2026-03-04 2026-03-03 4 Wyrick Susan D. SANA Common Stock F - Taxes D 3,9100 -491 -2 186.917
2026-03-04 2026-03-02 4 Wyrick Susan D. SANA Common Stock M - Exercise D 1.525 187.408
2026-01-06 2026-01-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 6.157 5.840.740
2026-01-06 2026-01-05 4 Wyrick Susan D. SANA Common Stock F - Taxes D 4,2700 -2.407 -10 185.883
2026-01-06 2026-01-02 4 Wyrick Susan D. SANA Common Stock M - Exercise D 7.500 188.290
2025-12-16 2025-12-15 4 Wyrick Susan D. SANA Common Stock F - Taxes D 5,2200 -873 -5 180.790
2025-12-16 2025-12-13 4 Wyrick Susan D. SANA Common Stock M - Exercise D 3.400 181.663
2025-12-05 2025-12-04 4 Wyrick Susan D. SANA Common Stock F - Taxes D 4,4400 -2.565 -11 178.263
2025-12-05 2025-12-03 4 Wyrick Susan D. SANA Common Stock M - Exercise D 10.000 180.828
2025-12-05 2025-06-04 4 Wyrick Susan D. SANA Common Stock F - Taxes D 2,3200 -2.567 -6 167.828
2025-12-05 2025-06-03 4 Wyrick Susan D. SANA Common Stock M - Exercise D 10.000 170.395
2025-10-07 2025-10-06 4 Bishop Hans Edgar SANA Common Stock A - Award D 5.628 5.834.583
2025-07-08 2025-07-07 4 Bishop Hans Edgar SANA Common Stock A - Award D 7.842 5.828.955
2025-04-08 2025-04-07 4 Bishop Hans Edgar SANA Common Stock A - Award D 16.339 5.821.113
2025-03-10 2025-03-10 4 Harr Steve SANA Common Stock F - Taxes D 2,5600 -12.820 -33 7.876.930
2025-03-10 2025-03-07 4 Harr Steve SANA Common Stock M - Exercise D 50.000 7.889.750
2025-03-10 2025-03-10 4 Cassidy Bernard J SANA Common Stock F - Taxes D 2,5600 -2.833 -7 112.990
2025-03-10 2025-03-07 4 Cassidy Bernard J SANA Common Stock M - Exercise D 11.041 115.823
2025-03-10 2025-03-10 4 Wyrick Susan D. SANA Common Stock F - Taxes D 2,5600 -836 -2 157.395
2025-03-10 2025-03-07 4 Wyrick Susan D. SANA Common Stock M - Exercise D 3.250 158.231
2025-03-03 2025-03-03 4 Wyrick Susan D. SANA Common Stock F - Taxes D 2,5600 -490 -1 154.981
2025-03-03 2025-03-02 4 Wyrick Susan D. SANA Common Stock M - Exercise D 1.525 155.471
2025-01-10 2025-01-08 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock S - Sale I 7,2600 -1.000 -7 4.541.511
2025-01-10 2025-01-08 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock S - Sale I 6,7100 -164.912 -1.107 4.542.511
2025-01-10 2025-01-08 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock S - Sale I 6,5000 -25.000 -162 4.707.423
2025-01-10 2025-01-08 4 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock S - Sale I 6,1100 -100.000 -611 4.732.423
2025-01-07 2025-01-06 4 Bishop Hans Edgar SANA Common Stock A - Award D 14.285 5.804.774
2025-01-03 2025-01-02 4 Wyrick Susan D. SANA Common Stock F - Taxes D 1,6500 -1.566 -3 153.946
2025-01-03 2025-01-02 4 Wyrick Susan D. SANA Common Stock M - Exercise D 5.000 155.512
2024-11-21 3/A FMR LLC / Fidelity Management & Research FMR Capital, Inc. SANA Common Stock I 61
2024-10-15 3 Wyrick Susan D. SANA Common Stock D 147.512
2024-10-09 2024-10-07 4 Bishop Hans Edgar SANA Common Stock A - Award D 5.938 5.790.489
2024-09-26 2024-09-25 4 Mulligan Richard SANA Common Stock S - Sale D 3,8878 -150.000 -583 2.698.121
2024-09-26 2024-09-24 4 Mulligan Richard SANA Common Stock S - Sale D 4,0838 -150.000 -613 2.848.121
2024-07-08 2024-07-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 4.911 5.784.551
2024-04-08 2024-04-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 2.774 5.779.640
2024-04-08 3 FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP SANA Common Stock I 4.832.423
2024-03-11 2024-03-08 4 Yang Patrick Y SANA Common Stock S - Sale D 9,4520 -25.000 -236 149.250
2024-02-12 2024-02-08 4 NELSEN ROBERT SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 NELSEN ROBERT SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 NELSEN ROBERT SANA Common Stock P - Purchase I 5,5000 363.637 2.000 10.667.387
2024-02-12 2024-02-08 4 CRANDELL KEITH SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 CRANDELL KEITH SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 CRANDELL KEITH SANA Common Stock P - Purchase I 5,5000 363.637 2.000 10.667.387
2024-02-12 2024-02-08 4 ARCH Venture Fund X, L.P. SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 ARCH Venture Fund X, L.P. SANA Common Stock P - Purchase I 5,5000 727.272 4.000 12.446.022
2024-02-12 2024-02-08 4 ARCH Venture Fund X, L.P. SANA Common Stock P - Purchase I 5,5000 363.637 2.000 10.667.387
2024-01-08 2024-01-05 4 Wilderotter Mary Agnes SANA Common Stock A - Award D 1.470 7.106
2024-01-08 2024-01-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 4.901 5.776.866
2023-12-18 2023-12-15 4 Hordo Christian SANA Common Stock S - Sale D 4,0013 -75.000 -300 867.455
2023-10-06 2023-10-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 6.925 5.771.965
2023-10-06 2023-10-05 4 Wilderotter Mary Agnes SANA Common Stock A - Award D 2.077 5.636
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI General Partner LLC SANA Common Stock J - Other I -70.813 0
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI, L.P. SANA Common Stock J - Other I -2.431.281 7.293.841
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship Ventures Fund V General Partner LLC SANA Common Stock J - Other I -1.181.745 0
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock J - Other I -345.069 1.035.208
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship Ventures Fund V, L.P. SANA Common Stock J - Other I -4.926.378 8.057.470
2023-09-15 2023-09-13 4 Flagship Ventures Management, Inc. By Flagship VentureLabs V, LLC SANA Common Stock J - Other I -2.825.989 8.615.337
2023-07-06 2023-07-05 4 Wilderotter Mary Agnes SANA Common Stock A - Award D 1.245 3.559
2023-07-06 2023-07-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 4.152 5.765.040
2023-06-08 2023-06-07 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,2397 -22.760 -142 1.380.277
2023-06-08 2023-06-07 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,2397 -177.240 -1.106 10.743.293
2023-06-08 2023-06-06 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,3061 -22.297 -141 1.403.037
2023-06-08 2023-06-06 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,3061 -181.461 -1.144 10.920.533
2023-05-26 2023-05-26 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,2265 -9.330 -58 1.425.334
2023-05-26 2023-05-26 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,2265 -72.670 -452 11.101.994
2023-05-26 2023-05-25 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,3522 -13.127 -83 1.434.664
2023-05-26 2023-05-25 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,3522 -102.245 -649 11.174.664
2023-05-26 2023-05-24 4 Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P. SANA Common Stock S - Sale I 6,5652 -39.580 -260 1.447.791
2023-05-26 2023-05-24 4 Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P. SANA Common Stock S - Sale I 6,5652 -308.290 -2.024 11.276.909
2023-04-06 2023-04-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 7.716 5.760.888
2023-04-06 2023-04-05 4 Wilderotter Mary Agnes SANA Common Stock A - Award D 2.314 2.314
2023-02-17 2021-02-03 4 Bilenker Joshua H. SANA Common Stock P - Purchase D 25,0000 20.000 500 20.000
2023-01-06 2023-01-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 6.702 5.753.172
2023-01-06 2023-01-05 4 NELSEN ROBERT SANA Common Stock A - Award D 536 1.353
2022-10-06 2022-10-05 4 NELSEN ROBERT SANA Common Stock A - Award D 321 817
2022-10-06 2022-10-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 4.012 5.746.470
2022-09-20 3/A Cassidy Bernard J SANA Common Stock D 92.781
2022-09-16 3 Cassidy Bernard J SANA Common Stock D 82.031
2022-07-07 2022-07-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 3.328 5.742.458
2022-07-07 2022-07-05 4 NELSEN ROBERT SANA Common Stock A - Award D 266 496
2022-06-15 2022-06-13 4 MacDonald James J. SANA Common Stock M - Exercise D 1,4800 66.796 99 497.396
2022-06-15 2022-05-13 4 MacDonald James J. SANA Common Stock A - Award D 4,2840 1.183 5 430.600
2022-04-15 2021-04-14 4 Harr Steve SANA Common Stock G - Gift D -167.000 7.839.750
2022-04-15 2021-04-14 4 Harr Steve SANA Common Stock G - Gift D -167.000 7.839.750
2022-04-06 2022-04-05 4 Bishop Hans Edgar SANA Common Stock A - Award D 2.880 5.739.130
2022-04-06 2022-04-05 4 NELSEN ROBERT SANA Common Stock A - Award D 230 230
2022-03-22 2022-03-21 4 Yang Patrick Y SANA Common Stock P - Purchase D 7,3000 28.000 204 174.250
2022-03-08 2022-03-03 4 Harr Steve SANA Stock Options (Right to Buy) A - Award D 5,70 760.000 760.000
2022-03-08 2022-03-03 4 AGARWAL SUNIL SANA Stock Options (Right to Buy) A - Award D 5,70 250.000 250.000
2022-03-08 2022-03-03 4 Mulligan Richard SANA Stock Options (Right to Buy) A - Award D 5,70 250.000 250.000
2022-03-08 2022-03-03 4 Hordo Christian SANA Stock Options (Right to Buy) A - Award D 5,70 225.000 225.000
2022-03-08 2022-03-03 4 MacDonald James J. SANA Stock Options (Right to Buy) A - Award D 5,70 225.000 225.000
2022-03-08 2022-03-03 4 Hardy Nathan SANA Stock Options (Right to Buy) A - Award D 5,70 225.000 225.000
2022-02-23 2022-02-18 4 MacDonald James J. SANA Common Stock S - Sale D 6,2800 -333 -2 429.417
2022-02-23 2021-11-15 4 MacDonald James J. SANA Common Stock A - Award D 18,2325 1.000 18 429.750
2021-09-17 2021-09-16 4 AGARWAL SUNIL SANA Common Stock S - Sale D 26,0000 -1.627 -42 1.550.000
2021-09-17 2021-09-15 4 AGARWAL SUNIL SANA Common Stock S - Sale D 26,0695 -58.373 -1.522 1.551.627
2021-09-14 2021-09-10 4 Hordo Christian SANA Common Stock S - Sale D 25,0000 -1.477 -37 942.455
2021-09-10 2021-09-09 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -39.205 88.803
2021-09-10 2021-09-09 4 Hordo Christian SANA Common Stock S - Sale D 25,0081 -25.466 -637 943.932
2021-09-10 2021-09-09 4 Hordo Christian SANA Common Stock S - Sale D 25,0130 -39.205 -981 969.398
2021-09-10 2021-09-09 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 39.205 58 1.008.603
2021-09-07 2021-09-03 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -700 128.008
2021-09-07 2021-09-03 4 Hordo Christian SANA Common Stock S - Sale D 25,0000 -700 -18 969.398
2021-09-07 2021-09-03 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 700 1 970.098
2021-09-07 2021-09-02 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -6.558 128.708
2021-09-07 2021-09-02 4 Hordo Christian SANA Common Stock S - Sale D 25,0039 -1.400 -35 969.398
2021-09-07 2021-09-02 4 Hordo Christian SANA Common Stock S - Sale D 25,0019 -6.558 -164 970.798
2021-09-07 2021-09-02 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 6.558 10 977.356
2021-09-03 2021-09-01 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -1.134 135.266
2021-09-03 2021-09-01 4 Hordo Christian SANA Common Stock S - Sale D 25,0057 -3.002 -75 970.798
2021-09-03 2021-09-01 4 Hordo Christian SANA Common Stock S - Sale D 25,0036 -1.134 -28 973.800
2021-09-03 2021-09-01 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 1.134 2 974.934
2021-09-01 2021-08-30 4 Hordo Christian SANA Stock Option (Right to Buy) M - Exercise D 1,48 -1.100 136.400
2021-09-01 2021-08-30 4 Hordo Christian SANA Common Stock S - Sale D 25,0183 -1.200 -30 973.800
2021-09-01 2021-08-30 4 Hordo Christian SANA Common Stock S - Sale D 25,0100 -1.100 -28 975.000
2021-09-01 2021-08-30 4 Hordo Christian SANA Common Stock M - Exercise D 1,4800 1.100 2 976.100
2021-04-27 2021-04-21 4 NELSEN ROBERT SANA Common Stock J - Other I 12.500 12.500
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 ARCH Venture Fund X, L.P. See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -11.585.199 0
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -11.441.326 0
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.725.122 0
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -1.487.371 0
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Common Stock C - Conversion I 11.585.199 11.585.199
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Common Stock C - Conversion I 11.441.326 11.441.326
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Common Stock C - Conversion I 9.725.122 9.725.122
2021-02-10 2021-02-08 4 Flagship Ventures Fund V General Partner LLC See footnotes SANA Common Stock C - Conversion I 1.487.371 1.487.371
2021-02-10 2021-02-08 4 Bishop Hans Edgar SANA Series B Convertible Preferred Stock C - Conversion D -156.250 0
2021-02-10 2021-02-08 4 Bishop Hans Edgar SANA Series A-2 Convertible Preferred Stock C - Conversion D -800.000 0
2021-02-10 2021-02-08 4 Bishop Hans Edgar SANA Series A-1 Convertible Preferred Stock C - Conversion D -1.075.000 0
2021-02-10 2021-02-08 4 Bishop Hans Edgar SANA Common Stock C - Conversion D 2.031.250 5.736.250
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -2.343.750 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series B Convertible Preferred Stock C - Conversion I -781.250 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -5.687.500 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-2 Convertible Preferred Stock C - Conversion I -9.375.000 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Series A-1 Convertible Preferred Stock C - Conversion I -3.687.500 0
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Common Stock C - Conversion I 11.718.750 11.718.750
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 NELSEN ROBERT See Footnotes SANA Common Stock C - Conversion I 10.156.250 10.301.250
2021-02-10 2021-02-08 4 von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT SANA Series A-2 Convertible Preferred Stock C - Conversion I -366.122 0
2021-02-10 2021-02-08 4 von Maltzahn Geoffrey SANA Series A-2 Convertible Preferred Stock C - Conversion D -1.464.488 0
2021-02-10 2021-02-08 4 von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT SANA Common Stock C - Conversion I 366.122 366.122
2021-02-10 2021-02-08 4 von Maltzahn Geoffrey SANA Common Stock C - Conversion D 1.464.488 1.464.488
2021-02-10 2021-02-08 4 Harr Steve SANA Series B Convertible Preferred Stock C - Conversion D -156.250 0
2021-02-10 2021-02-08 4 Harr Steve SANA Series A-2 Convertible Preferred Stock C - Conversion D -800.000 0
2021-02-10 2021-02-08 4 Harr Steve SANA Series A-1 Convertible Preferred Stock C - Conversion D -1.075.000 0
2021-02-10 2021-02-08 4 Harr Steve SANA Common Stock C - Conversion D 2.031.250 8.173.750
2021-02-10 2021-02-08 4 MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 SANA Series B Convertible Preferred Stock C - Conversion I -7.812 0
2021-02-10 2021-02-08 4 MacDonald James J. SANA Series A-1 Convertible Preferred Stock C - Conversion D -93.750 0
2021-02-10 2021-02-08 4 MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10 SANA Common Stock C - Conversion I 7.812 7.812
2021-02-10 2021-02-08 4 MacDonald James J. SANA Common Stock C - Conversion D 93.750 428.750
2021-02-05 2021-02-03 4 NELSEN ROBERT SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 von Maltzahn Geoffrey SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 Bishop Hans Edgar SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 AGARWAL SUNIL SANA Stock Option (Right to Buy) A - Award D 25,00 48.000 48.000
2021-02-05 2021-02-03 4 Bilenker Joshua H. SANA Stock Option (Right to Buy) A - Award D 25,00 7.000 7.000
2021-02-05 2021-02-03 4 Cole Douglas G. SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 Wilderotter Mary Agnes SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 Seitz Michelle SANA Stock Option (Right to Buy) A - Award D 25,00 7.000 7.000
2021-02-05 2021-02-03 4 Yang Patrick Y SANA Stock Option (Right to Buy) A - Award D 25,00 14.000 14.000
2021-02-05 2021-02-03 4 REICIN ALISE SANA Stock Option (Right to Buy) A - Award D 25,00 7.000 7.000
2021-02-03 3 AGARWAL SUNIL SANA Common Stock D 1.610.000
2021-02-03 3 NELSEN ROBERT See Footnotes SANA Common Stock I 147.500
2021-02-03 3 NELSEN ROBERT See Footnotes SANA Common Stock I 145.000
2021-02-03 3 GILLIS STEVEN See Footnotes SANA Common Stock I 145.000
2021-02-03 3 GILLIS STEVEN See Footnotes SANA Common Stock I 147.500
2021-02-03 3 ARCH Venture Partners X, LLC See Footnotes SANA Common Stock I 145.000
2021-02-03 3 ARCH Venture Partners X, LLC See Footnotes SANA Common Stock I 147.500
2021-02-03 3 Hordo Christian SANA Common Stock D 975.000
2021-02-03 3 Yang Patrick Y SANA Common Stock D 146.250
2021-02-03 3 MacDonald James J. SANA Common Stock D 335.000
2021-02-03 3 MacDonald James J. Held by the KOM Trust SANA Common Stock I 125.000
2021-02-03 3 MacDonald James J. Held by the NMM Trust SANA Common Stock I 125.000
2021-02-03 3 Mulligan Richard SANA Common Stock D 2.998.121
2021-02-03 3 Harr Steve Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015 SANA Common Stock I 682.500
2021-02-03 3 Harr Steve SANA Common Stock D 6.142.500
2021-02-03 3 Bishop Hans Edgar SANA Common Stock D 3.705.000
2021-02-03 3 Hardy Nathan SANA Common Stock D 511.250
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista